Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
GRANULES | BSE
-1.20
-0.31%
Healthcare
Drug Manufacturers-Specialty & Generic
30/09/2023
04/12/2023
391.50
400.55
400.55
390.45
Granules India Limited manufactures and sells active pharmaceutical ingredients (APIs) pharmaceutical formulation intermediates and finished dosages (FDs) in India North America Europe Latin America Africa the Middle East and internationally. The company's APIs in various therapeutic categories include anti-retrovirals anti-hypertensives anti-histamines anti-infectives analgesics anti-coagulants anti-fibriotics and platelet inhibitors. It also offers various FDs such as tablets caplets and press-fit capsules in bulk blister packs and bottles; and other specialty products for oncology. The Company also exports its products. Granules India Limited was founded in 1984 and is based in Hyderabad India.
View LessPositive Momentum
Low 6-Month Volatility (<30%)
Low Market Beta (-0.4 to 0.8)
High Short-term Volatility
Smallcap (300M - 2B USD)
Weak Sharpe Ratio (< 0.3)
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
10 days
38.3%1 month
30.5%3 months
31.7%6 months
29.1%24.16
15.41
3.09
0.47
0.26
12.86
2.27
0
8.09B
94.92B
1.14B
0.38
13.49
-27.50
3.40
14.16
0
0
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
44.90
Range1M
58.20
Range3M
102.95
Rel. volume
0.56
Price X volume
20.59M